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INTRODUCTION: Sternal wound infections (SWI) are a
prominent concern after cardiac surgery due to associated
morbidity and mortality. Recent observational studies have
evaluated the use of vancomycin with a cephalosporin as
surgical prophylaxis to broaden coverage against resistant
organisms, with varying results. This study investigated the
effect of vancomycin and a cephalosporin compared to a
cephalosporin alone on overall incidence of SWI after cardiac
surgery.
METHODS: This single-center retrospective cohort study
included all patients who underwent cardiac surgery requiring
preoperative antibiotic prophylaxis between January and
November 2020. Patients with left ventricular assist device
implantation, concomitant infectious pathology, receipt
of other antibiotics within 24 hours, or allergy to betalactams were excluded. Patients who received preoperative
vancomycin with a cephalosporin were included in the
combination therapy group and compared to patients who
received a cephalosporin alone. Case-matching based on the
presence of diabetes and body mass index was performed
to minimize confounding. The primary outcome of this study
was overall postoperative SWI within 30 days. This outcome
was assessed using a chi square test with a p-value less than
0.05 indicating significance.
RESULTS: Of the 339 analyzed patients, 184 patients met
criteria for inclusion. There was no significant difference
in incidence of overall SWI between monotherapy and
combination groups (3 versus 4 respectively, p=0.69). There
were also no significant differences in secondary outcomes
including but not limited to 30-day mortality, readmission,
or reoperation. Incidence of acute kidney injury (AKI) was
numerically higher in the combination therapy group, although
this was not significant.
CONCLUSIONS: Addition of vancomycin to a cephalosporin
did not reduce incidence of SWI prior to cardiac surgery and
may have increased incidence of adverse events such as
AKI. However, this study is limited by sample size, and more
research is needed to determine impact of patient-specific
risk factors.
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INTRODUCTION: Mycobacterium bovis infection in humans
is an extremely rare entity. M. tuberculosis and M. bovis
are clinically and radiographically indistinguishable, hence,
genotype-based identification is required. Management
and outcomes of M. bovis infection are not well described.
We present the first case of endobronchial tuberculosis
secondary to M. bovis in an immunocompetent host.
DESCRIPTION: A 19 year old woman without past
medical history presented to the emergency department for
sudden onset left-side chest pain and dry cough. A preoccupational evaluation noted a positive tuberculin skin test
with normal chest-xray. Physical exam significant for absent
breathing sounds in the left upper lung. Laboratory tests
include leukocyte count of 9.8 bil/L, hemoglobin of 11 gr/
dL and procalcitonin of 0.02ng/mL. Computed Tomography
of the chest showed complete left upper lobe collapse
with obstruction of the left main bronchial lumen and left
side pneumothorax ex-vacuo. Emergency bronchoscopy
revealed a partially obstructed left mainstem bronchus with
erythematous, friable mucosa and granular white tissue.
Balloon dilation was performed successfully and samples
from bronchoalveolar lavage (BAL) and biopsy of the
granular tissue were obtained. Acid Fast Bacilli in Sputum
and Quantiferon tests resulted negative, but Protein Chain
Reaction analysis of BAL came positive for Mycobacterium
tuberculosis and the patient was started on rifampicin,
isoniazid, pyrazinamide and ethambutol (RIPE) therapy. BAL
culture grew Mycobacterium bovis identified by pyrazinamide
monoresistance, confirmed by the Michigan Department
of Health and Human Services. At 6 months follow up,
the patient complained of a lingering cough, wheezing
and shortness of breath. Bronchoscopy control showed
recurrence of initial lesions that required balloon dilation.
Cultures obtained grew Aspergillus spp and the patient was
started on voriconazole.
DISCUSSION: To our knowledge, ours is the first case
report of M. bovis presenting with endobronchial obstruction
without parenchymal compromise in an otherwise healthy
patient. We aim to highlight the diagnostic challenges of this
rare case: extremely low incidence of the disease, nonspecific
presentation, absent risk factors and high rate of short term
complications despite treatment.
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